PTGX

Protagonist Therapeutics (PTGX)

Protagonist Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PTGX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/12	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/06/08	05 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/05/08	05 : 51	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/05/08	05 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/04/16	22 : 00	GlobeNewswire Inc.	Turnstone Biologics Appoints William Waddill to its Board of Directors	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	10 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	10 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	10 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	06 : 32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/01	07 : 48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/29	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/28	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/14	21 : 47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/14	21 : 15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/01	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/19	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/19	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/16	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/12	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/10	07 : 25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/08	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2023/12/19	06 : 15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PTGX	Protagonist Therapeutics Inc
2023/11/03	06 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTGX	Protagonist Therapeutics Inc